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IsoﬂuraneMitochondrial bioenergetic studies mostly rely on isolated mitochondria thus excluding the regulatory role
of other cellular compartments important for the overall mitochondrial function. In intact cardiomyocytes,
we followed the dynamics of electron ﬂuxes along speciﬁc sites of the electron transport chain (ETC) by
simultaneous detection of NAD(P)H and ﬂavoprotein (FP) ﬂuorescence intensities using a laser-scanning
confocal microscope. This method was used to delineate the effects of isoﬂurane, a volatile anesthetic and
cardioprotective agent, on the ETC. Comparison to the effects of well-characterized ETC inhibitors and
uncoupling agent revealed two distinct effects of isoﬂurane: uncoupling-induced mitochondrial depolariza-
tion and inhibition of ETC at the level of complex I. In correlation, oxygen consumption measurements in
cardiomyocytes conﬁrmed a dose-dependent, dual effect of isoﬂurane, and in isolated mitochondria an
obstruction of the ETC primarily at the level of complex I. These effects are likely responsible for the reported
mild stimulation of mitochondrial reactive oxygen species (ROS) production required for the cardioprotec-
tive effects of isoﬂurane. In conclusion, isoﬂurane exhibits complex effects on the ETC in intact
cardiomyocytes, altering its electron ﬂuxes, and thereby enhancing ROS production. The NAD(P)H-FP
ﬂuorometry is a useful method for exploring the effect of drugs on mitochondria and identifying their
speciﬁc sites of action within the ETC of intact cardiomyocytes.sport chain; UQ , ubiquinone;
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Mitochondria play a crucial role under physiological and patho-
logical conditions, and as such were recognized as important target
for therapeutic interventions [1]. Volatile anesthetics, such as
isoﬂurane, have cardioprotective properties against ischemia and
reperfusion injury that were previously associated with their effects
on mitochondria [2]. This includes a moderate increase in reactive
oxygen species (ROS) production that triggers prosurvival signaling[3]. Cellular signaling of isoﬂurane-induced protection is complex, and
includes various prosurvival kinases and mitochondrial and sarco-
lemmal potassium channels [4,5]. Mitochondria act as upstream
trigger and as downstream effector of volatile anesthetic-induced
cardioprotection. However, the reports on isoﬂurane's effects on
mitochondria are contradictory, ranging from mitochondrial uncou-
pling to inhibition of various complexes of the ETC [2,6–8]. We have
shown that cardiac mitochondria isolated from isoﬂurane-precondi-
tioned rats exhibit mild depolarization and uncoupling, which may
limit the damaging matrix Ca2+ accumulation without adversely
affecting ATP production [2]. These events likely act as effectors of
APC, reducing the extent of mitochondrial damage after hypoxic
stress. In addition, volatile anesthetics, by nature of their lipid
solubility, may also directly alter mitochondrial function, including
oxidative phosphorylation, ROS production and ion transport,
constituting the triggering phase of the APC.
The complexity of mitochondrial function that is under regulation
of other cellular compartments, such as cytosol and endoplasmic
reticulum [9,10] is often overlooked when reductionist models like
isolated mitochondria or permeabilized cells are used. Ratiometric
redox ﬂuorometry of endogenous pyridine nucleotides NAD(P)H and
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within their natural milieu of intact cells. Changes in the NADH/NAD+
redox couple dominate the NAD(P)H ﬂuorometry [11,12]. Upon
NADH oxidation, electrons are transferred to complex I and, via
ubiquinone (UQ), proceed downstream to O2, the ﬁnal electron
acceptor (Fig. 6A). The overall FP ﬂuorescence signal originates from
three sources: (1) lipoamide dehydrogenase (LipDH), where the
redox state of the ﬂavin moiety is coupled to NADH/NAD+, (2)
electron transfer ﬂavoprotein (ETF), in redox contact with UQ via ETF-
ubiquinone oxidoreductase (ETF-QO), and 3) non-speciﬁc FPs which
are not in redox contact with the ETC and contribute only ~25% to the
overall signal in rat liver mitochondria [13–15].
Based on different electron pathways originating from NADH and
ETF, we used simultaneous NAD(P)H-FP ﬂuorometry to assess
changes of electron ﬂuxes along different parts of the ETC in non-
permeabilized cardiomyocytes. This approach was undertaken to
determine the speciﬁc sites of action of the isoﬂurane within the ETC
using a whole-cell approach that was supported by measurements in
isolated mitochondria. Our results indicate that isoﬂurane exhibits
dual, dose-dependent effects on the ETC in cardiomyocytes and
thereby alters electron pathways, enhancing ROS production and
triggering cardioprotective signals. NAD(P)H-FP ﬂuorometry is a
useful technique capable of delineating pharmacological agent's
speciﬁc sites of action within the ETC of intact cells.
2. Materials and methods
The animal use and experimental protocols of this study were
approved by the Institutional Animal Use and Care Committee of the
Medical College of Wisconsin, Milwaukee, WI.
2.1. Isolation of cardiomyocytes
Ventricular cardiomyocytes were obtained from male Wistar rats
(180–250 g), as reported previously [3]. In brief, hearts from rats
anesthetizedwith sodium thiobutabarbital (Inactin, Sigma-Aldrich, St.
Louis, MO; 150 mg/kg intraperitoneally) were excised and perfused
retrogradely through an aortic cannula with a buffer containing a
mixture of collagenase and protease. After dissociation, myocytes
were placed in Tyrode's solution containing (in mM): 132 NaCl, 10
HEPES, 5 glucose, 5 KCl, 1 CaCl2, 1.2 MgCl2, pH 7.4, and experiments
were conducted within 5 h after cell isolation.
2.2. Isolation of cardiac mitochondria
Mitochondria were isolated following a previously reported
procedure [2]. Hearts were excised from anesthetized rats and left
ventricles were minced in isolation buffer (in mM): 50 sucrose, 200
mannitol, 5 KH2PO4, 1 EGTA, 5 3-(N-morpholino)propanesulfonic
acid, 0.1% bovine serum albumin and adjusted to pH 7.3. The tissue
was homogenized twice for 5 s with a T 25 disperser (IKA-Werke,
Staufen, Germany), and mitochondria were isolated by differential
centrifugation. The ﬁnal mitochondrial pellet was resuspended in
isolation buffer without EGTA, stored on ice, and used for experiments
within 4 h. Protein concentration was determined by a modiﬁed
Lowry assay kit (Bio-Rad, Hercules, CA).
2.3. NAD(P)H-FP ﬂuorometry in cardiomyocytes
A laser-scanning confocal microscope (Leica TCS SP5, Mannheim,
Germany) with a 63×/1.4 Apo oil objective was utilized to monitor
NAD(P) and FP ﬂuorescence intensities in cardiomyocytes at 30 °C.
Consecutive laser-scans at 730 nm (titanium:sapphire laser, Spectra
Physics, Mountain View, CA) and 488 nm (argon laser) were used for
quasi-simultaneous two-photon NAD(P)H excitation and single-
photon FP excitation, respectively. Each 512×512 pixel imagerepresents an average of six scans taken with a resonant scanner at
8000 Hz. Emission bands of NAD(P)H and FPs were collected at 390–
490 nm and 500–530 nm wavelength, respectively. This allowed
sufﬁcient separation between NAD(P)H and FP emission bands for
independent quantiﬁcation of their ﬂuorescence intensities [16]. Data
were processed with LAS AF software (Leica). The excitation power
was controlled with acousto-optic tunable ﬁlters (AOTFs) whereby
the excitation power of the titanium:sapphire laser was set at 12.5% of
maximum. The power supply of the argon laser was set to 20% of
maximum and the excitation line was attenuated to 15% of maximum.
At these excitation powers, no photodamage was observed, that
would be indicated by a change in cell behavior or ﬂuorescence
intensities. Based solely on the emitted ﬂuorescence, the three major
groups of ﬂuorescent FPs cannot be distinguished with certainty,
although the emission wavelengths were set to match emission
spectrum of the ETF [17]. Nonetheless, a functional distinction
between ﬂuorescence of LipDH and ETF can be obtained [15,18,19],
as discussed later. Fluorescence intensity data are normalized to
baseline, expressed as 100%. The change in ﬂuorescence (ΔF) is
calculated as difference between baseline value and the effect of drug
after reaching a plateau, where each value is an average of ﬁve to ten
consecutive data points.
2.4. Mitochondrial membrane potential (ΔΨm) measurements in
cardiomyocytes
Cardiomyocytes were loaded with the potentiometric ﬂuorescent
indicator tetramethylrhodamine ethyl ester (TMRE, 100 nM, Invitro-
gen, Carlsbad, CA) for 10 min in the absence or presence of isoﬂurane.
TMRE ﬂuorescence intensity was acquired using the confocal
microscope at excitation and emission wavelengths: λex/λem=543/
570–610.
2.5. Cardiomyocyte O2 consumption
Respiration of isolated cardiomyocytes supported by endogenous
substrates was measured in Tyrode's solution at 37 °C using an O2
electrode (Hansatech Instruments, Norfolk, UK). While other experi-
ments were conducted at 30 °C, these measurements were performed
at higher temperature to enhance respiration and thereby increase
the ability to detect changes. In the cell suspensions, more than 70% of
cardiomyocytes were alive and rod-shaped. After establishing
baseline rate of O2 consumption, isoﬂurane was added at incremental
concentrations and results were normalized to baseline values.
2.6. Isolated mitochondria O2 consumption
Mitochondrial O2 consumption was measured with an O2
electrode at 30 °C in respiration buffer (130 mM KCl, 5 mM K2HPO4,
20 mM MOPS, 2.5 mM EGTA, 1 μM Na4P2O7 and 0.1% BSA, pH 7.4)
containing 1.0 mg/ml mitochondrial protein in the presence or
absence of isoﬂurane [2]. State 2 respiration was initiated with
5 mM pyruvate and malate or 5 mM succinate and 2 μM rotenone.
State 3 respiration was measured in the presence of 250 μM ADP, and
after all ADP was consumed, state 4 respiration was determined.
2.7. Cardiomyocyte ROS production
ROS production in isolated cardiomyocytes wasmonitored at 30 °C
using the confocal microscope. The ROS-sensitive indicator 5-(and-
6)-chloromethyl-2',7'-dichlorodihydroﬂuorescein diacetate, acetyl
ester (CM-H2DCFDA, 2 μM, Invitrogen), was loaded for 20 min,
followed by 10 min dye washout [3]. Oxidation of deesteriﬁed CM-
H2DCF by ROS yields ﬂuorescent CM-DCF (λex/λem=488/500–
550 nm). The CM-DCF ﬂuorescence intensity was assessed 10 min
after exposure to isoﬂurane or vehicle (control).
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Mitochondrial ROS production was measured at state 2 respiration
using Amplex Red (12.5 μM, Invitrogen) and 0.1 U/ml horseradish
peroxidase at 30 °C. Amplex Red reacts with H2O2 in the presence of
peroxidase to produce the ﬂuorescent resoruﬁn. Resoruﬁn ﬂuores-
cence intensity was measured with a spectroﬂuorometer (Photon
Technology International, Birmingham, NJ), λex/λem=530/583 nm.
ROSmeasurements were conducted in the presence of 5 mMpyruvate
and 5 mM malate in respiration buffer containing mitochondria at a
ﬁnal concentration of 1 mg protein/ml. Measurements were calibrat-
ed with known concentrations of H2O2.
2.9. Administration of isoﬂurane
The appropriate volumes of stock solution of isoﬂurane dissolved
in dimethyl sulfoxide (DMSO, Sigma-Aldrich) were added to
experimental buffers, to achieve a desired concentrations of isoﬂurane
(0.25, 0.5, or 1 mM). At the end of each experiment isoﬂurane
concentration was analyzed by gas chromatography, and it varied ±
10% of the reported values. DMSO alone was added in appropriate
controls, its concentrations were below 0.2% and it did not affect
measured parameters.
2.10. Statistical analysis
Data are presented as means±SEM, where N represents the
number of independent experiments. Results were analyzed using
analysis of variance with the Bonferroni's post hoc test, and Student t
test for individual isoﬂurane concentrations in NAD(P)H-FP ﬂuorom-
etry experiments. Differences at Pb0.05 were considered signiﬁcant.
3. Results
3.1. Alterations in cardiomyocyte ETC electron pathways detected by
NAD(P)H-FP ﬂuorometry
The protonophore 2,4-dinitrophenol (DNP) and ETC inhibitors were
used to induce speciﬁc alterations in the electron pathways within the
ETC, and changes in NAD(P)H and FP ﬂuorescence intensities were
recorded simultaneously. DNP decreased NAD(P)H and increased FP
ﬂuorescence intensity indicating oxidation of each ﬂuorophore due to
the increase in electron delivery into the ETC (Fig. 1A–C). Inhibition of
complex IV by cyanide caused an increase inNAD(P)H and a decrease in
FP ﬂuorescence intensity, indicating blocked electron transfer into the
ETC and the reduction of electron carriers by endogenous substrates
(Fig. 1D and E). Rotenone, an inhibitor of complex I, increasedNAD(P)H
ﬂuorescence intensity due to inhibited NADH oxidation (Fig. 1F and G).
FP ﬂuorescence intensities also slightly increased due to increased
electron transfer from ETF to UQ caused by increased oxidation of UQ
pool [15]. Thenoyltriﬂuoreroacetone (TTFA), a complex II inhibitor,
induced decrease in NAD(P)H and increase in FP ﬂuorescence intensity
again due to oxidation of UQ pool and increased electron transfer to
UQ from unobstructed pathways that involve NADH and ETF (Fig. 1H
and I).
3.2. In cardiomyocytes, isoﬂurane exhibits two distinct effects,
mitochondrial uncoupling and inhibition of ETC at the level of complex I
The effects of isoﬂurane on the ETC of cardiomyocytes were
analyzed by NAD(P)H-FP ﬂuorometry. At all concentrations, isoﬂur-
ane increased FP and decreased NAD(P)H ﬂuorescence intensities
indicating oxidation of the respective ﬂuorophore (Fig. 2A–D), which
qualitatively resembled the effects of DNP and TTFA. Isoﬂurane also
reduced TMRE ﬂuorescence compared to control, indicating mito-
chondrial depolarization (Fig. 2F and G). While isoﬂurane dose-dependently increased FP oxidation, NADH oxidation was attenuated
at 1 mM isoﬂurane. This indicated a partial obstruction of the ETC at
the level of complex I, thus affecting the NADH but not the ETF
pathway. The decrease in the ratio of ﬂuorescence intensity change of
NAD(P)H to FP at 1 mM isoﬂurane, which reﬂects the relative
contribution of electron transfer in each pathway (NADH→complex
I→UQ and ETF→ETF-QO→UQ) conﬁrmed the obstruction of
electron ﬂow at the level of complex I (Fig. 2E).
3.3. In cardiomyocytes, isoﬂurane dose-dependently alters respiration
The O2 consumption rate was used as an indirect estimate of the
overall rate of electron transfer along the ETC in the presence of
isoﬂurane. At 0.25 mM concentration, isoﬂurane increased the rate of
O2 consumption by 22±6% compared to baseline (Fig. 3). However,
higher concentrations of isoﬂurane 0.5 and 1 mM, reversed the trend
and isoﬂurane attenuated O2 consumption by 5±9 and 17±8%,
respectively. The increase in O2 consumption indicates increased
electron ﬂow through the ETC that can be caused by mitochondrial
uncoupling [20], identiﬁed as one effect of isoﬂurane by NAD(P)H-FP
ﬂuorometry. The attenuation of O2 consumption at higher isoﬂurane
concentrations indicates decrease in electron transfer along the ETC,
identiﬁed by NAD(P)H-FP ﬂuorometry as inhibition of the ETC at the
level of complex I. Compared to maximal and minimal respiration
stimulated by DNP and cyanide, respectively, the effects of isoﬂurane
were mild.
3.4. In isolated cardiac mitochondria, isoﬂurane inhibits ETC
predominantly at the level of complex I
To conﬁrm the speciﬁc site of ETC obstruction by isoﬂurane, the
lowest concentration of 0.5 mM at which cardiomyocyte respiration
was attenuated was tested in isolated mitochondria. The rate of O2
consumption was measured when delivering electrons into ETC via
complex I using pyruvate/malate or via complex II using succinate
and rotenone. As shown in Fig. 4A and C, isoﬂurane decreased the
rates of respiration at states 2, 3, and 4 compared to control when
mitochondria were fueled with pyruvate/malate (11.2±0.8 vs.
17.2 ± 1.4 , 49.9 ± 7.6 vs. 99.3 ± 7.4 , and 13.6 ± 1.0 vs .
18.4±3.0 nmol O2 min−1 mg protein−1, respectively). In contrast,
with the complex II substrate succinate and in the presence of
rotenone, O2 consumption was not signiﬁcantly altered in the
presence of 0.5 mM isoﬂurane at respiration states 2 and 4. There
was an inhibition at state 3 respiration, but to lesser extent than with
pyruvate/malate (isoﬂurane vs. control: 142.0±16.5 vs.
164.1±21.8 nmol O2 min−1 mg protein−1) (Fig. 4B and D). When
measured in the absence of rotenone, succinate-induced respiration
was 109±13.5 nmol O2 min−1 mg protein−1 without isoﬂurane, and
124.0±min−1 mg protein−1 with isoﬂurane. Overall, these data
indicate a predominant obstruction of the ETC at the level of complex
I by isoﬂurane and possibly a lesser pronounced obstruction between
complexes II and IV.
3.5. Isoﬂurane enhances ROS production in cardiomyocytes and in
isolated mitochondria
The production of ROS in the presence or absence of isoﬂuranewas
monitored in cardiomyocytes and in isolated mitochondria. In
cardiomyocytes, 0.25, 0.5 and 1 mM isoﬂurane increased CM-DCF
ﬂuorescence intensity by 9±9, 18±8 and 35±10% of control,
respectively, indicating a dose-dependent increase in ROS production
(Fig. 5A–C). To test whether isoﬂurane-induced ROS production
originated from mitochondria, isoﬂurane was applied to isolated
mitochondria and ROS production was measured by spectroﬂuorom-
etry. At state 2 respiration supported by pyruvate/malate, 0.5 mM
isoﬂurane enhanced the rate of increase in resoruﬁn ﬂuorescence
Fig. 1. NAD(P)H-FP ﬂuorometry and electron ﬂuxes in the ETC. Time courses, (B, D, F and H) and summary histograms of relative ﬂuorescence intensity change (ΔF), (C, E, G and I).
Oxidation decreases NAD(P)H and increases FP ﬂuorescence intensity and reduction induces the opposite response of each electron carrier. (A) Representative images of NAD(P)H
and FP ﬂuorescence before and after treatment with mitochondrial uncoupler DNP(100 μM). (B and C) DNP increased FP and decreased NAD(P)H ﬂuorescence intensity. (D and E)
CN− (2 mM), a complex IV inhibitor, decreased FP and increased NAD(P)H ﬂuorescence intensity. (F and G) Complex I inhibitor rotenone (1 μM) enhanced FP and NAD(P)H
ﬂuorescence intensity. (H and I) TTFA (50 μM), a complex II inhibitor, increased FP and decreased NAD(P)H ﬂuorescence intensity. Data are means±SEM, N=6–8/group.
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Fig. 2. Dual effect of isoﬂurane on the ETC detected by NAD(P)H-FP ﬂuorometry. FP (A and C) and NAD(P)H (B and D) ﬂuorescence intensity recordings after addition of various
concentrations of isoﬂurane (Iso). While FPs became progressively oxidized with increasing isoﬂurane concentrations, NAD(P)H oxidation exhibited a bell-shaped concentration
dependence. Summary data in panels C and D are average time points in time frame 200–400 s. (E) The ratio between NAD(P)H and FP ﬂuorescence intensity change decreased at
1 mM isoﬂurane suggesting a relative decrease of electron ﬂux in the pathway NADH→complex I→UQ compared to the pathway ETF→ETF-QO→UQ. (F) Isoﬂurane dose-
dependently decreased TMRE ﬂuorescence intensity compared to control (Con), reﬂecting a decrease in ΔΨm. (G) Representative images of TMRE ﬂuorescence in cardiomyocytes.
Data are means±SEM, N=10–12/group. ⁎Pb0.05; #Pb0.05 vs. Con.
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Fig. 3. Dose-dependent effect of isoﬂurane on cardiomyocyte O2 consumption. (A)
Representative signal trace of O2 consumption measurement of cardiomyocytes after
the addition of incremental isoﬂurane (Iso) concentrations. (B) Summarized data from
14 experiments are expressed as the rate of O2 consumption normalized to baseline. At
lower concentrations, isoﬂurane enhanced O2 consumption, but at higher concentra-
tions, the trend was reversed and isoﬂurane attenuated O2 consumption. DMSO, a
vehicle for isoﬂurane, did not signiﬁcantly affect respiration. Maximal and minimal O2
consumption was induced in the presence of DNP (100 μM) and sodium cyanide
(2 mM), respectively. Values are means±SEM. ⁎Pb0.05 vs. Baseline; #Pb0.05 vs. Iso
0.25 mM.
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protein−1, respectively), indicating stimulation of ROS production by
isoﬂurane (Fig. 5D and E). Inhibition of complex I with rotenone
induced a greater increase in ROS production than isoﬂurane
(22.3±3.7 pmol H2O2 min−1 mg protein−1), suggesting only a mild
effect of isoﬂurane.4. Discussion
We demonstrated a dual effect of isoﬂurane on the mitochondrial
ETC in cardiomyocytes: uncoupling-induced mitochondrial depolar-
ization and inhibition of the ETC at the level of complex I. This novel
application of NAD(P)H-FP ﬂuorometry allows monitoring of
electron ﬂuxes along distinct sites of ETC in intact cells. With this
method, the effects of pharmacological agents on speciﬁc sites of the
ETC can be analyzed with the advantage of encompassing mechan-
isms involving other cellular organelles. The uncoupling-induced
mitochondrial depolarization revealed by NAD(P)H-FP ﬂuorometry
corresponds to the enhanced rates of O2 consumption by cardio-
myocytes at lower isoﬂurane concentrations, and the inhibition of
the ETC at the level of complex I corresponds to the attenuation of O2
consumption by cardiomyocytes at higher isoﬂurane concentrations.
In isolated mitochondria, substrate-dependent O2 consumptionmeasurements conﬁrm that complex I is the predominant site of
ETC inhibition by isoﬂurane. The identiﬁed alteration of electron
ﬂuxes within the ETC caused by isoﬂurane is likely to be responsible
for the enhanced ROS production, an important trigger for car-
dioprotective signaling.
4.1. NAD(P)H-FP ﬂuorometry and ETC
We have demonstrated that simultaneous recording of NAD(P)H
and FP ﬂuorescence intensity changes gives distinct responses to
speciﬁc alterations of electron ﬂow within the ETC. This is in accord
with previous studies that characterized the NAD(P)H-FP ﬂuoro-
metric responses to manipulation with the ETC in isolated mito-
chondria and permeabilized cells [15]. The ﬂuorescence intensity of
each ﬂuorophore is in linear correlation with its redox state, tying
the changes in ﬂuorescence intensities to alterations of electron
transfer via these electron carriers [21,22]. Consistent with the
model depicted in Fig. 6A, we showed that an uncoupling agent
oxidized NAD(P)H and FPs. A decrease in the ΔΨm and the proton
gradient across the inner mitochondrial membrane accelerates
electron transfers into ETC via upstream electron carriers, causing
oxidation of both NADH and FPs (LipDH and ETF) [23]. Conversely,
cyanide reduced both NAD(P)H and FP due to the obstruction of
electron ﬂow at complex IV, causing accumulation of the reduced
electron carriers. Similarly, it has been shown that the depletion of
the ﬁnal electron acceptor O2, or obstruction of complex III with
myxothiazol, slows oxidation of electron carriers in the upstream
pathways that converge at UQ, leading to more reduced FPs and
NADH [24,25]. Complex I inhibitor rotenone reduced NAD(P)H to a
similar extent as cyanide [26]. However, rotenone also slightly
increased FP oxidation, which we attributed to the increased
ﬂuorescence of ETF. This observation is supported by Kunz et al.
who demonstrated that the UQ/ubiquinol (UQH2) couple equili-
brates with ETF and controls the rate of electron transfer from ETF to
ETC [15]. Therefore, an increased UQ/UQH2 ratio caused by rotenone
(due to attenuated reduction of UQ by electrons arriving from
complex I) increases electron transfer rate from ETF to UQ causing
ETF oxidation [15]. While rotenone blocks oxidation of LipDH
[26,27], we observed that the oxidation of ETF predominated in the
overall FP ﬂuorescence intensity change. Under baseline conditions
in energized cells FPs, including LipDH, are almost completely
reduced (as observed in Fig. 1: DNP induces a substantially greater FP
ﬂuorescence intensity change than cyanide). Thus, only a small
portion of predominantly reduced LipDH ﬂavin can be further
reduced by rotenone, compared to the greater portion of ETF that
becomes oxidized. Lastly, complex II inhibition by TTFA oxidized
NAD(P)H and FP. We presume that similar to the effect of rotenone,
complex II inhibition attenuated UQ reduction by blocking electron
ﬂux from complex II, thereby increasing the UQ/UQH2 ratio, which in
turn increases electron transfer to UQ from unobstructed pathways
involving NADH and both FPs.
4.2. Isoﬂurane and NAD(P)H-FP ﬂuorometry
The observed oxidation of NAD(P)H and FPs induced by
isoﬂurane was qualitatively comparable to the effects of DNP or
TTFA. Isoﬂurane-induced depolarization of mitochondria and oxida-
tion of FPs has been associated with opening of mitochondrial ATP-
sensitive K+ channels [2], suggesting that electron carrier oxidation
observed here is caused by uncoupling-induced mitochondrial
depolarization (Fig. 6B). However, the possibility of a mild complex
II inhibition cannot be excluded since isoﬂurane partly obstructed O2
consumption in isolated mitochondria respiring on succinate, as
discussed below. The attenuation of NAD(P)H oxidation at 1 mM
isoﬂurane compared to the lower doses, together with dose-
dependent FP oxidation, suggests the obstruction in the pathway
Fig. 4. Isoﬂurane inhibits ETC of isolatedmitochondria primarily at the level of complex I. Representative respiration recordings of isolatedmitochondria in the absence (Con) andpresence
of isoﬂurane (Iso, 0.5 mM)usingpyruvate/malate (PM) (A)or succinate (Succ) (B) as substrates. (C) Summarizeddata for PMshow that compared to control, the rate ofO2 consumption at
states 2, 3 and 4 was attenuated in the presence of Iso. (D) With Succ as substrate, isoﬂurane slightly attenuated O2 consumption only at state 3. Data are means±SEM, N=5–6/group.
⁎Pb0.05 vs. Con.
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possibility that complex I inhibition by isoﬂurane is alone respon-
sible for the decrease in ΔΨm is excluded since isoﬂurane and
rotenone caused opposite NAD(P)H responses. Isoﬂurane caused
oxidation of FP as well as NAD(P)H due to concomitant uncoupling,
while rotenone caused a reduction in NAD(P)H and mild FP
oxidation solely due to complex I inhibition. Cardiomyocyte res-
piration measurements veriﬁed the existence of a dual effect of
isoﬂurane, as discussed below.
4.3. O2 consumption
While measurements of O2 consumption in cardiomyocytes reﬂect
only the overall rate of electron ﬂux through the ETC, these results
were in agreement with our NAD(P)H-FP ﬂuorometry results. At
lower concentrations, isoﬂurane increased the rate of O2 consump-
tion, indicating increase in the overall rate of electron ﬂow along the
ETC caused by uncoupling. However, at higher concentrations,
isoﬂurane reversed this trend and attenuated O2 consumption,
suggesting a decrease in electron ﬂow through the ETC due to an
inhibitory effect. This correlates with the inhibition of ETC at the level
of complex I identiﬁed by NAD(P)H-FP ﬂuorometry. In isolated
mitochondria, when electrons were delivered to the ETC via complex
I, isoﬂurane substantially attenuated O2 consumption at all respiration
states. When electrons were delivered downstream of complex I, by
succinate via complex II, only a minor inhibition of mitochondrial
respiration at state 3 by isoﬂurane was observed. This indicates that
isoﬂurane inhibited ETC primarily at the level of complex I.
Measurements with succinate in the absence of rotenone supported
this connotation. Oxalacetate, formed in the citrate cycle when NADH
levels decrease in the absence of rotenone, is a potent inhibitor ofsuccinate dehydrogenase. In addition, reverse electron ﬂow from
complex II to complex I is known to stimulate production of reactive
oxygen species under these conditions. Isoﬂurane reduced the decline
in state 3 respiration observed in the absence of rotenone. This may be
explained by isoﬂurane-induced complex I inhibition and thus,
increasing NADH level and less oxalacetate production, as well as
reduced reverse electron ﬂow. However the possibility of an
additional mild inhibition of other complexes cannot be excluded.
The absence of isoﬂurane-induced increase in state 4 respiration that
would be expected in the presence of uncoupling, may be due to
concomitant inhibition of ETC overriding the effect of uncoupling on
the overall rate of electron ﬂow. Alternatively, mitochondrial
uncoupling may result from an action of isoﬂurane that involves
presence of other cellular compartments. The latter is suggested by
previous ﬁndings that isoﬂurane induces translocation of protein
kinase C from the cytosol to mitochondria [4] and subsequent
activation of mitochondrial ATP-sensitive K+ channels, causing
uncoupling [28,29].
In the presence of 0.5 mM isoﬂurane, respiration at state 3
supported by pyruvate/malate exhibits an unsteady character
(Fig. 4A), similar to the biphasic response of the NAD(P)H-FP
ﬂuorometric measurement at the same isoﬂurane concentration
(Fig. 2, A and B). We speculate that the effect of complex I inhibition
and uncoupling are comparable at 0.5 mM isoﬂurane, as suggested by
cardiomyocyte respiration experiments (Fig. 3B), where uncoupling
and ETC inhibition exist in parallel. Fluctuations in the extent of
uncoupling or complex I inhibition and the transient predominance of
each effect may be responsible for less stable signals at 0.5 mM
isoﬂurane. These ﬂuctuations could be potentiated by a time-
dependent redistribution of lipophilic isoﬂurane between membrane
compartments.
Fig. 5. Isoﬂurane increases ROS production in cardiomyocytes andmitochondria. (A) Representative images of CM-DCF ﬂuorescence in cardiomyocytes. (B) Summary of signal traces
of CM-DCF ﬂuorescence intensity as indication of ROS production before and after addition of 0.5 mM isoﬂurane (Iso). (C) Summarized values of CM-DCF ﬂuorescence intensity in
control or after the treatment with various concentrations of Iso. (D) Representative traces of resoruﬁn ﬂuorescence intensity measurements in mitochondria with pyruvate and
malate (PM) as substrate in the absence (Con) and presence of 0.5 mM Iso. (E) Summarized and calibrated rates of increase in resoruﬁn ﬂuorescence intensity in Con, Iso or rotenone
(Rot, 1 μM)-treated mitochondria. Data are means±SEM, N=6–10/group. ⁎Pb0.05 vs. Con.
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Previous reports that isoﬂurane inhibits complex I [7], other
complexes of the ETC [30] or induces mitochondrial uncoupling via
mitochondrial K+ channels [2] brought some confusion in elucidating
the effects of volatile anestheticsonmitochondria,which is important for
cardioprotection [1]. A moderate increase in ROS production was
suggested to trigger these cardioprotective mechanisms [3]. Cardiopro-
tective agents, including volatile anesthetics may generate ROS by
openingmitochondrial K+ channels [31–33]. Moreover, complex III was
proposed as the site of isoﬂurane-induced ROS production [34]. The dual
effect of isoﬂurane on the ETC observed in our study, that is mild
uncoupling combinedwith inhibition of the ETC at the level of complex I
could readily be considered asmechanism for ROSgeneration at complex
I [35,36], or potentially at complex III. The latter is implied by a study by
Drose et al. showing that an increasedUQ/UQH2 ratio, here generated by
obstruction of complex I, enhances ROS production at complex III [37].In conclusion, we demonstrated that simultaneous NAD(P)H-FP
ﬂuorometry can be used as simple and useful approach for the analysis
of electron ﬂuxes along the ETC in intact cardiomyocytes to delineate
speciﬁc sites of action of drugs within the ETC. Using this approach, we
identiﬁed a complex action of isoﬂurane that included uncoupling-
inducedmitochondrial depolarization and inhibition of complex I. These
effects are likely the base for the mechanism by which isoﬂurane
moderately enhances ROS production, an important trigger of cardio-
protective pathways.Acknowledgments
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Fig. 6. Electron pathways through the ETC fromNADH and ﬂuorescent FPs and the effects of isoﬂurane. (A) NADH is oxidized to NAD+while shuttling electrons to complex I, UQ, and
downstream to the ﬁnal electron acceptor O2. LipDH ﬂavoprotein is in redox equilibriumwith the NADH/NAD+ redox couple and its ﬂuorescence intensity follows changes in NADH
ﬂuorescence. ETF is in redox contact with UQ pool. After oxidation of ETF electrons are transferred to UQ via ETF-QO (not shown). Separate entry sites of electrons arriving from
NADH and ETF result in their independent redox and ﬂuorescence responses to distinct alternations of the electron ﬂowwithin the ETC. (B) A dual effect of isoﬂurane on the ETC: (1)
an uncoupling-induced mitochondrial depolarization that is observed as increased oxidation of NAD(P)H and FPs and correlates with increased rate of cardiomyocyte O2
consumption at lower isoﬂurane concentrations, and (2) inhibition of electron ﬂux at the level of complex I that is observed as attenuation of NAD(P)H oxidation compared to
oxidation of FPs (ETF) and correlates with the attenuation of cardiomyocyte O2 consumption at higher isoﬂurane concentrations. (LipDH—lipoamid dehydrogenase, Comp.—
complex, ETF—electron transfer ﬂavoprotein, UQ—ubiquinone, Cyt C—cytochrome C, ΔΨm—mitochondrial membrane potential).
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